Etiquette-Based Neonatology

Keir A: “Please call my baby by her name…”. Acta Paediatrica 2013. This should be self-evident, but this publication in the Acta Paediatrica ‘different view’ section notes that it is not. Knowing whether the baby is a boy or a girl, and knowing their name (if the parents have decided on one) looking the parents in the eye when you talk to them, should we really have to teach doctors to do those things? I guess we do. Annie and I with Barb Farlow have written a review article about making difficult decisions in the NICU that should be published shortly, as a little taster, here is one part of our recommendations for communicating with parents about difficult issues. (As usual this was Annie’s list initially, ‘etiquette based neonatology’, is her copyrighted term for it). The following is a section quoted from the upcoming article.

When you talk to parents:

‘-Limit the number of Health Care Providers attending difficult conversations or complicated deliveries.

-Make sure you do not get interrupted: ask a colleague to cover the delivery room or take your pager.

-A baby is not a “23-weeker” or “a difficult case of NEC”. If a baby has a name, you should know it and use it.

-Have difficult conversations in a place that is suitable for the parents.

-Do the parents want a significant support person present? Wait for that person if time permits.

-Introduce yourself to the parents.

-Explain your role in the team caring for their baby and why you are there.

-Sit down for difficult conversations.

-Listen more than you talk; tolerate silence.

Some may sigh and find this list is obvious and patronizing. Experiences of parents show, however, that these basic human interactions may be neglected

(Janvier A, Farlow B, Wilfond BS: The Experience of Families With Children With Trisomy 13 and 18 in Social Networks. Pediatrics 2012.)’

Posted in Neonatal Research | 5 Comments

Public Citizen, still full of shit

Sorry to any of my readers who are offended by the ‘olde englishe’ term for solid waste matter, I could have said s**t or crap I guess, but I am getting a bit irritated by the stream of b******s (liquid waste matter from a flying mammal) coming from the source cited.

The campaign by Drs Carome and Wolfe of Public Citizen in the USA against the SUPPORT trial continues. They again show they know nothing about clinical research or about neonatology or about the difference between an arse and an elbow (a second olde englishe expression). They have tried to rebut John Lantos’s refutation of their nonsense, and again show that they seem to think that the babies in the trial were exposed to some risks that the investigators  tried to keep hidden.

They again suggest (and are joined by another commenter) that a 3rd group receiving ‘standard of care’ should have been enrolled. They are unable to understand that the 2 groups were both already ‘standard of care’.

I added my two penn’orth (another olde englishe expression meaning worth 2 (old) pennies) to the Bioethics Forum. I was a bit rude, so it might get edited, if so, I will repost the unedited version here. Otherwise, go to the link and, if you feel so inclined you can register and add your own comments.

I tried to find a place on the Public Citizen website to leave a comment, but there is nowhere to do so. Which is a little internet version 1.0, but also, for an organization that purports to be ‘the people’s voice’ is an indication that they don’t want to hear the people’s voice.

All of which is quite a shame, the politics of Public Citizen, other than this completely unjustified attack on SUPPORT, are very much in line with my own. They should just shut up and apologize for all this nonsense, but I am pretty sure that will not happen. It is hard to just say, ‘sorry, we were wrong, it was a great study that will improve outcomes for preterm babies, without increasing any kind of risks for the participants, carry on the good work’.

Posted in Neonatal Research | 2 Comments

Needless

One of the blogs that I follow, and which does not post very frequently, is by David Colquhoun, he is (or was) a professor of pharmacology at University College London, who writes mostly about the inappropriate teaching of quackery as if it were science in the UK. His latest column quotes in its entirety an article about acupuncture that he wrote for “Anesthesia and Analgesia” entitled “Acupuncture is a theatrical placebo: the end of a myth” his co-author is one of the founders of “Science Based Medicine” which publishes a lot of interesting anti-quackery, pro-scientific medicine, posts. This new article by David Colquhoun and Steve Novella is a well written take-down of all the anti-scientific nonsense that purveyors of acupuncture will spout. If you want, or need, a quick rebuttal to those who will try and tell you that acupuncture is proven to work by good scientific studies, you could do no better than to read this.

Posted in Neonatal Research | Leave a comment

Adaptation at birth and cord clamping

The guys in Melbourne have a great set up, the 2 universities collaborate, as well as working with colleagues from Sydney also. Stuart Hopper is a very innovative thinker who has re-examined a lot of older data about what happens at birth, and has a good scientific approach, but always an eye on what the clinical implications are. This latest study (Bhatt S, Alison BJ, Wallace EM, Crossley KJ, Gill AW, Kluckow M, te Pas AB, Morley CJ, Polglase GR, Hooper SB: Delaying cord clamping until ventilation onset improves cardiovascular function at birth in preterm lambs. The Journal of Physiology 2013, 591(8):2113-2126._ Examined the effects of ventilating lambs before or after the cord was clamped. The animals were instrumented before birth, then when they were delivered by cesarean, they intubated the animals. They either then cut the cord and started ventilation 2 minutes later, or started ventilation with the cord unclamped, and clamped it when the pulmonary artery flow had increased (about 3.7 minutes on average). Delayed clamping had the following benefits:

  • ”ventilation prior to cord clamping markedly improves cardiovascular function by increasing pulmonary blood flow before the cord is clamped, thus further stabilising the cerebral haemodynamic transition.

  • These results show that delaying cord clamping until after ventilation onset leads to a smoother transition to newborn life, and probably underlies previously demonstrated benefits of delayed cord clamping.”

It is really starting to l0ok like the default should be to ventilate the baby BEFORE clamping the cord: even if the baby is a little bradycardic (the lambs who were clamped first dropped their heart rates, the ventilation first lambs did not), systemic blood flows were much better after this process than after immediate clamping. The clinical studies will confirm whether this is safe and effective in the very preterm, but this study gives us some mechanistic data that support the change in practice. (In addition we already know in older preterm infants and term babies that delayed clamping increases hemoglobin and reduces later transfusions).

Posted in Neonatal Research | 3 Comments

Neonatal Updates #33

McElroy SJ, Underwood MA, Sherman MP: Paneth Cells and Necrotizing Enterocolitis: A Novel Hypothesis for Disease Pathogenesis. Neonatology 2013, 103(1):10-20. (free access)I think this is an interesting idea that might be fruitful for the future. If the hypothesis is correct, it might explain some of the efficacy of probiotics and of lactoferrin. And it might give a target for future preventive therapies. This is not one of those Monty Python type theories, but seems to have significant evidence to support it.

Thayyil S, Sebire NJ, Chitty LS, Wade A, Chong W, Olsen O, Gunny RS, Offiah AC, Owens CM, Saunders DE et al: Post-mortem MRI versus conventional autopsy in fetuses and children: a prospective validation study. Lancet 2013(0). Study which compared autopsy findings to findings on what was called minimally invasive autopsy. This consisted of a whole body MRI with some needle sampling to obtain cultures. The minimally invasive method was quite accurate for the fetus, and the newborn (less so for older children). Autopsy rates have been declining, often leaving us with many unanswered questions. This might be a good alternative if we can’t get consent for full autopsy, which seems to be more and more difficult.

Jenke AC, Zilbauer M, Postberg J, Wirth S: Human beta-defensin 2 expression in ELBW infants with severe necrotizing enterocolitis. Pediatr Res 2012, 72(5):513-520. This molecule, Hbd2, is part of the innate immune system of the neonate. Levels were high in chorio-amnionitis, and were also high in most cases of NEC, in the most severe cases the levels were low, suggesting maybe a failure of immune defenses in the worst cases.

Rios DR, Welty SE, Gunn JK, Beca J, Minard CG, Goldsworthy M, Coleman L, Hunter JV, Andropoulos DB, Shekerdemian LS: Usefulness of Routine Head Ultrasound Scans Before Surgery for Congenital Heart Disease. Pediatrics 2013. Evidence that supports what many of us have long thought, that head ultrasounds are useless for screening for congenital CNS anomalies. They are OK for finding central cerebral hemorrhagic lesions, but for trying to see if there are CNS malformations, or subtle white matter abnormalities, don’t bother. Get an MRI instead… if you need to know.

The following series of articles are from a new issue of Seminars of Fetal and Neonatel Medicine, all about perinatal palliative care, and all interesting, and generally well written.

Mancini A, Kelly P, Bluebond-Langner M: Training neonatal staff for the future in neonatal palliative care. Seminars in Fetal and Neonatal Medicine 2013, 18(2):111-115.

Larcher V: Ethical considerations in neonatal end-of-life care. Seminars in Fetal and Neonatal Medicine 2013, 18(2):105-110.

Woodroffe I: Supporting bereaved families through neonatal death and beyond. Seminars in Fetal and Neonatal Medicine 2013, 18(2):99-104.

Craig F, Mancini A: Can we truly offer a choice of place of death in neonatal palliative care? Seminars in Fetal and Neonatal Medicine 2013, 18(2):93-98.

Carter BS, Jones PM: Evidence-based comfort care for neonates towards the end of life. Seminars in Fetal and Neonatal Medicine 2013, 18(2):88-92.

Laing IA: Conflict resolution in end-of-life decisions in the neonatal unit. Seminars in Fetal and Neonatal Medicine 2013, 18(2):83-87.

Cacciatore J: Psychological effects of stillbirth. Seminars in Fetal and Neonatal Medicine 2013, 18(2):76-82.

Breeze ACG, Lees CC: Antenatal diagnosis and management of life-limiting conditions. Seminars in Fetal and Neonatal Medicine 2013, 18(2):68-75.

Posted in Neonatal Research | Leave a comment

Travelling, again

Posting has been light last week and will continue to be for the next week. I was at a conference in St John, New Brunswick, last week (presentations now available on the blog, under New Brunswick 2013) and I am now on my way to Helsinki, by way of St Petersburg. Because of the vagaries of airplane ticket pricing, it was actually cheaper for me to come to St Petersburg and return from Helsinki than to buy a return ticket to Helsinki. As I have always wanted to visit this city it was easy to decide which option to take (even though it means I am away from home for too long).

The city is exactly as I imagined, being built in a swamp by this guy:2013-05-27 19.11.27to be his new capital in the 18th century, if my memory serves me right. That is Czar Peter the first. I was once in Kiev in the Ukraine to do some teaching; and when talking about history with a guide that I had for a side trip,  I was told off for calling him Peter ‘the Great’; the Ukrainians didn’t think he was great!

I have to correct the previous section, the city wasn’t built by Peter, it was built by hundreds of thousands of poor serfs, forced into labour by his armed forces, many thousands of whom died during the construction of his vanity project. With the distance of time, one can see a beautiful city, but it is strange, given the Communist history, there are monuments to Peter, but I haven’t yet seen one to the people who died building this place.

Posted in Not neonatology | 1 Comment

Probiotics in the NICU: a ‘how-to’ guide

I have had several communications from people interested in starting the use of probiotics in their nurseries. There are often roadblocks, and some reluctance from either infection control, or pharmacy and therapeutics committees (or both).

I will recount what we went through at Sainte-Justine to get probiotics to our babies.

When I arrived here 4 1/2 years ago (time flies) I was already convinced that probiotics were the way to go. My first inquiries about using probiotics were not fruitful, but I worked with one of our NICU pharmacists to produce a document formally applying for the addition of a probiotic mixture to the hospital formulary. I investigated the different preparations available and at that time got into contact with someone who works with a probiotic manufacturer (Harmonium International) who have their facility not far from Montreal. He is the one who really got me informed about the Health Canada Natural Products Directorate, what an NPN (natural product number) means, the DNA registration database for probiotics (there are several) and the different preparations available. After the document was prepared I went with the pharmacist to the pharmacy committee, they were very reluctant, wanted some time to consider, wanted to confer with the infection control docs, and asked me to consider how we would evaluate the effects. I was hopeful, however: it wasn’t an outright no.

At about the same time, we had a mother in our NICU whose baby was born about 24 1/2 weeks gestation, the baby had a ‘NEC scare’ and subsequently the mother came to me, telling me she had read about probiotics on the internet, that she already gave probiotics to her other children, and she would like her baby to have them.

Now we had previously had some parents want to give their baby herbal medicines, and, if we were able to be fairly sure that the preparation was safe, then we have facilitated this. So in this new situation, and my pre-existing desire to give probiotics anyway, I told the mother that if she wanted to go and buy a preparation with a Health Canada NPN, that had a lactobacilllus and at least one bifidobacterium in it, (and I gave her 2 choices of mixtures that I thought were appropriate) and bring it to the NICU, then we would give it to her baby.

From then it snowballed, several parents wanted to give their babies probiotics, when they asked me about it I told them about the evidence, (at the time there were ‘only’ 17 RCTs with ‘only’ 3,000 babies randomized; showing no adverse effects, no infections with probiotic organisms, a reduction in NEC and a reduction in mortality). It was, and still is, the only intervention, other than breast milk, which is proven to prevent NEC.  A number of parents decided to buy their own probiotics. By now it seemed a little random who was getting probiotics and who was not, so I wrote an information letter for the parents, to be given on admission. Applying the ethical principle of justice, I didn’t want some parents to be informed but not others.

By this time the hospital was a bit unhappy with me, and asked me to go back to the Pharmacy committee, so the pharmacist (Josianne Malo) and I re-applied to the pharmacy committee, by this time our infectious disease people had confirmed, by taking a sample from one of the tubs that a parent had brought to the hospital, that they can grow the organisms in our lab, and that they didn’t find any pathogens.

The pharmacy committee asked me to perform an objective prospective evaluation of the effects of introducing probiotics into our NICU, we developed a standing order form to be completed on admission, and wrote a protocol to control how they were used.

The current protocol:

All babies under 32 weeks gestation admitted to the NICU within the first 3 days of life are eligible.

Babies with congenital GI anomalies are excluded

Starting with the first feed 0.5g of florababy(TM) are given mixed with 1 ml of water, once a day just before a feed.

Florababy is continued to 34 weeks post-menstrual age, and then stopped (unless the parents ask us to continue, which has been rare).

If the baby is put npo the florababy is also stopped, and then restarted with the feeds.

As we were unwilling to perform a randomized trial with untreated controls, the pharmacy committee agreed that a prospective cohort study would be acceptable. We obtained permission from the research ethics board to perform the cohort study, and a retrospective chart review to get some historical controls. We planned an 18 month collection period to get a sample size of about 300 per group.

I think we have been successful because

1. there was a conjunction of circumstances, including the particular mother involved in our first ‘case’.

2. I was bloody minded enough to keep pushing.

3. My colleagues were supportive, especially Annie who helped to push this through.

4. Our NICU pharmacist was very helpful, to write the documents in a way that would work with the committee.

5. Discussions with Infection Control focused on the risk/benefit balance and not just on the risks, and they were receptive. (In fact the risks are tiny, no adverse effects despite over 5000 babies in the trials)

6. The pharmacy committee were open to the initiative.

I must emphasize that the Health Canada NPN does not mean that probiotics are approved by Health Canada for the prevention of NEC. It does mean that the manufacturers follow GMP, and that there is adequate quality control in inspected factories. It means for probiotics that the DNA of the strains is registered. So it basically means that you are getting what you think you are getting. It also means that any health claims on the label have been approved, (I think this label says ‘maintains intestinal health’ or something equally vague).

I think the key to getting over the objections here was really the infection control groups understanding of the importance of NEC prevention in the face of a lack of documented risks. Once you get them on-side, or at least not in the opposition camp, then you can probably win.

Or rather, it is the babies that win.

Posted in Neonatal Research | Tagged , , , | 2 Comments

What we don’t know about neonatal endocrinology #3, the thyroid.

To finalize this litany of the unknown… We also need to know whether low thyroxine levels are common in the preterm (they are) what the consequences are (associated with worse long term outcomes) whether they are causative (don’t know) and whether replacement with exogenous thyroxine is a good idea or not (haven’t got the slightest).

In older patients they talk about the sick euthyroid syndrome: critically ill older patients have a suppression of thyroid function, which appears to be adaptive, but maybe not. In any case as a recent review for adults (free access) notes, “there is currently no convincing evidence to suggest that restoring physiological thyroid hormone concentrations in unselected patients with NTIS would be beneficial” NTIS being another term for the sick euthyroid syndrome.

This review article from last year (La Gamma E, Paneth N. Clinical importance of hypothyroxinemia in the preterm infant and a discussion of treatment concerns. Current Opinion in Pediatrics. 2012;24(2):172-80) is pretty complete.  Ed LaGamma and Nigel Paneth review the data regarding thyroid dysfunction in the very preterm infant. I reproduce the table of key points below, but please get access to the full article if you can, it is well written (as you would expect from those two) and quite complete. I think investigating preterm infants thyroid function could be very important for improving preterm outcomes.

Also don’t forget, dopamine is very efficient at suppressing thyroid function, as is well known in adults, and also in babies, as Istvan Seri showed many years ago (Seri I, Tulassay T, Kiszel J, Ruppert F, Sulyok E, Ertl T, et al. Effect of low-dose dopamine infusion on prolactin and thyrotropin secretion in preterm infants with hyaline membrane disease. Biol Neonate. 1985 1985;47(6):317-22) and confirmed several times since, (Filippi L, et al. Dopamine infusion: a possible cause of undiagnosed congenital hypothyroidism in preterm infants. Pediatric critical care medicine.  2006 May;7(3):249-51). So many very sick babies are getting dopamine, and this has often been ignored in the reports of the studies of thyroid function in the preterm infant, we often do not know how many were on dopamine, which really makes interpretation of the published data complicated.

Graphic

All of which makes me think that, for a neonatal fellow looking for an academic career path, you could do worse than neonatal endocrinology… if you speak French (you don’t have to be fluent, just the basics will do, you will become fluent very quickly), drop me a line, we have great endocrinologists at my hospital, Sainte Justine in Montreal, and we could create a new super-fellowship! In addition to the neonatology and neonatology/clinical ethics fellowships that are already very active and very high quality.

Posted in Neonatal Research | Tagged | Leave a comment

What we don’t know about neonatal endocrinology #2, blood sugar regulation.

As a follow on to the previous post, also to highlight a thoughtful review article, we could ask whether blood sugar can be too low to be good for you  (I think there is not much doubt about that) how to define hypoglycemia (probably varies according to the context) how to diagnose it (may take more than a blood sugar, and certainly not a bedside strip test) and whether it helps to treat it (only if you get the diagnosis right, can probably cause harm when you treat a normal baby).

The review in question (Hawdon JM: Definition of neonatal hypoglycaemia: Time for a rethink? Archives of disease in childhood Fetal and neonatal edition 2013.) points out that when metabolic adaptation is intact babies can mobilize and use other sources of energy, and probably don’t need intervention at all, even if the blood sugar is as low as 1 mmol/L. She also notes that babies with hyperinsulinism have these adaptations completely suppressed.

So here is the problem, how to identify those babies that have intact adaptation mechanisms, and those that don’t. Because a proportion of babies with normal or low birth weight will have hyperinsulinism, not just the obvious infant of a diabetic mother. I am not sure that deciding if the infant is symptomatic is very good at differentiating either, the symptoms often listed are so non-specific that almost any baby could be symptomatic. Perhaps what we really need is a quick simple reliable point-of-care test of blood sugar which is combined with indicators of adequate metabolic response, or insulin levels. Many babies are currently getting screened and treated, only a proportion of which are probably benefiting. I think that is probably the best we can do for the moment, but we need to pursue this further for the future.

Posted in Neonatal Research | Leave a comment

What we don’t know about neonatal endocrinology #1, the adrenals.

I once wrote a paper with the last author of this article, when we were both working in Edmonton, so I will have to be nice, I guess. Seriously, we do need to know a lot more about adrenal responses to being born very preterm, whether relative adrenal insufficiency exists (I think it probably does) how to define it (I have no idea, which makes the first answer a bit redundant) how to diagnose it (nope, no idea here either) and whether it helps to treat it (not a clue).

These investigators from Vancouver have made a decent attempt to find some more answers.  Hochwald O, Holsti L, Osiovich H: The use of an early acth test to identify hypoadrenalism-related hypotension in low birth weight infants. J Perinatol 2012, 32(6):412-417. They performed ACTH stimulation tests on 40 babies from 24 to 29 weeks gestation, in the first 8 hours of life and then followed them to see if they got treated for hypotension. They also performed echos to look at cardiac function before treatment for low BP, or at 8 hours if the babies were not treated.
They noted that their practice is to only treat infants for “hypotension” if they have a mean BP less than the GA and clinical signs and symptoms of decreased capillary perfusion, and lack of response to a 10 ml/kg bolus. That is similar to what I would describe that I do, but they had 30% of the infants getting treated for hypotension, whereas I treat far fewer than 30% in the first 8 hours of life. Which points out only that some of these decisions are rather subjective, and the diagnosis of hypotension needing treatment is uncertain.

They found that babies who had less than a 12% rise in their cortisol with the test were more likely to get treated with inotropes, and that cutoff was relatively specific for getting treated (93%), with a 75% sensitivity.

They also measured left ventricular output by echo at the time of treatment, or if not treated at 8 hours of age. I am not sure why they chose to measure LVO; in this group of babies the ductus arteriosus will be open almost 100% of the time at these ages, so LVO is critically dependent on ductal shunting, and is likely to change rapidly as pulmonary vascular resistance falls, so if the non-treated group were studied a little later (as they will be by design, being studied at 8 hours of age) the ductal shunt may be larger, and thus give a higher LVO. Indeed LVO was higher in the non-treated babies: I must say though that in the treated babies, after the fluid bolus but before the inotrope, the LVOs were quite low, 66 to 120 mL/kg/min. That is very low, so probably a truly low systemic flow. Compared to between 135 and 266 ml/kg/min in the untreated babies at 8 hours of age. That very large difference is probably not all due to differences in ductal shunt, but I still don’t understand why they didn’t measure RVO instead.

When they analyzed the LVO by whether the ACTH test had a low response or a high response, there was much more overlap. Low ACTH response LVO = 118 (range 66–202) high response LVO= 179 (range 90–266) ml/kg/min. So the means were significantly different, but there is not good discrimination between the groups.

So this study suggests that having a low ACTH response makes you more likely to get treated for hypotension accompanied by poor perfusion, and is associated with a variably lower LVO.

The article is accompanied by an editorial (Aucott SW: The challenge of defining relative adrenal insufficiency. J Perinatol 2012, 32(6):397-398) which points out the difficulties in defining relative adrenal insufficiency, and the lack of good evidence to guide management, including steroid replacement.

Posted in Neonatal Research | Tagged , | Leave a comment